Cargando…

Multicenter analysis of stereotactic radiotherapy of the resection cavity in patients with brain metastases

Brain metastases show a recurrence rate of about 50% after surgical resection. Adjuvant radiotherapy can prevent progression; however, whole‐brain radiotherapy (WBRT) can be associated with significant side effects. Local hypofractionated stereotactic radiotherapy (HFSRT) is a good alternative to pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Combs, Stephanie E., Bilger, Angelika, Diehl, Christian, Bretzinger, Eva, Lorenz, Hannah, Oehlke, Oliver, Specht, Hanno M., Kirstein, Anna, Grosu, Anca‐Ligia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010760/ https://www.ncbi.nlm.nih.gov/pubmed/29696815 http://dx.doi.org/10.1002/cam4.1477

Ejemplares similares

Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection
por: Bilger, Angelika, et al.
Publicado: (2018)

Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)
por: Nieder, Carsten, et al.
Publicado: (2017)

Validation of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)
por: Nieder, Carsten, et al.
Publicado: (2018)

Local control and overall survival after frameless radiosurgery: A single center experience
por: Bilger, Angelika, et al.
Publicado: (2017)

Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial
por: Waltenberger, Maria, et al.
Publicado: (2023)

Validation of the graded prognostic assessment for gastrointestinal cancers with brain metastases (GI-GPA)
por: Nieder, Carsten, et al.
Publicado: (2020)

Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) – a phase II prospective randomized multicenter trial (NOA-14, ARO 2015–3, DKTK-ROG)
por: Grosu, Anca-Ligia, et al.
Publicado: (2020)

The challenge of durable brain control in patients with brain-only metastases from breast cancer
por: Nieder, Carsten, et al.
Publicado: (2015)

Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
por: Guckenberger, Matthias, et al.
Publicado: (2020)

Stereotactic radiosurgery (SRS) for brain metastases: a systematic review
por: Nieder, Carsten, et al.
Publicado: (2014)

Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review
por: Gong, Yining, et al.
Publicado: (2019)

A prospective study of immune responses in patients with lung metastases treated with stereotactic body radiotherapy with or without concurrent systemic treatment
por: Duda, Dan, et al.
Publicado: (2023)

Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
por: Gutschenritter, Tyler, et al.
Publicado: (2020)

Postoperative Cavity Stereotactic Radiosurgery for Brain Metastases
por: Marchan, Eduardo M., et al.
Publicado: (2018)

Stereotactic Body Radiotherapy for Prostate Cancer
por: Parikh, Neil R., et al.
Publicado: (2020)

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
por: Gkika, Eleni, et al.
Publicado: (2017)

Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery
por: Tazi, Karim, et al.
Publicado: (2015)

Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity
por: Toesca, Diego A.S., et al.
Publicado: (2018)

Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection—Outcome, Prognostic Factors, and Recurrence Patterns
por: El Shafie, Rami A., et al.
Publicado: (2020)

Efficacy of Stereotactic Body Radiotherapy in Patients With Hepatocellular Carcinoma Not Suitable for Transarterial Chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)
por: Brunner, Thomas B., et al.
Publicado: (2021)

Unresectable hepatic PEComa: a rare malignancy treated with stereotactic body radiation therapy (SBRT) followed by complete resection
por: Kirste, Simon, et al.
Publicado: (2018)

Re‐irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score—report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK)
por: Combs, Stephanie E., et al.
Publicado: (2018)

Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma
por: Gkika, Eleni, et al.
Publicado: (2017)

RONC-06. Stereotactic radiosurgery and stereotactic radiotherapy for pediatric brain metastases or recurrences
por: McGovern, Susan, et al.
Publicado: (2022)

Stereotactic Body Radiotherapy for Renal Cell Carcinoma in Patients with Von Hippel–Lindau Disease—Results of a Prospective Trial
por: Kirste, Simon, et al.
Publicado: (2022)

Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case‐control study (PAULA‐1)
por: Arcelli, Alessandra, et al.
Publicado: (2020)

The Role of Palliative Radiotherapy in the Treatment of Spinal Bone Metastases from Head and Neck Tumors—A Multicenter Analysis of a Rare Event
por: Bostel, Tilman, et al.
Publicado: (2020)

Treatment of Sarcoma Lung Metastases with Stereotactic Body Radiotherapy
por: Lindsay, Adam D., et al.
Publicado: (2018)

Systematic Review of the Role of Stereotactic Radiotherapy for Bone Metastases
por: Spencer, Katie L, et al.
Publicado: (2019)

Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases
por: Gutiérrez, Enrique, et al.
Publicado: (2021)

Colorectal Pulmonary Metastases: Pulmonary Metastasectomy or Stereotactic Radiotherapy?
por: van Dorp, Martijn, et al.
Publicado: (2023)

Simple immobilization for stereotactic radiotherapy aimed at pelvic metastases
por: Janssen, Jorinde, et al.
Publicado: (2023)

Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis
por: Calderon, Benoît, et al.
Publicado: (2023)

A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial
por: Pasquier, David, et al.
Publicado: (2023)

Neuroendocrine Carcinoma of Uterine Cervix: Stereotactic Radiotherapy for Brain Metastasis and Stereotactic Body Radiotherapy for Renal and Pancreatic Metastases
por: Mori, Yoshimasa, et al.
Publicado: (2020)

Dose Reduction to Motor Structures in Adjuvant Fractionated Stereotactic Radiotherapy of Brain Metastases: nTMS-Derived DTI-Based Motor Fiber Tracking in Treatment Planning
por: Diehl, Christian D., et al.
Publicado: (2022)

Technical Considerations in Stereotactic Ablative Radiotherapy for Localized Neuroendocrine Cancer of the Lung: Case Report and Review of the Literature
por: Callan, Laura, et al.
Publicado: (2018)

Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
por: Nieder, Carsten, et al.
Publicado: (2023)

A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4–10 brain metastases
por: Hartgerink, Dianne, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_np31eib61kg40rt87nfjq5555a